Honored to have been selected for the New Investigator Award from the International Society for CNS Clinical Trials and Methodology! This recognition aligns with my passion for advancing rigorous and innovative research methodologies to improve psychiatric care. #ISCTM #ISCTM2025
February 18, 2025 at 10:09 PM
Honored to have been selected for the New Investigator Award from the International Society for CNS Clinical Trials and Methodology! This recognition aligns with my passion for advancing rigorous and innovative research methodologies to improve psychiatric care. #ISCTM #ISCTM2025
A huge thank you to my mentors, colleagues, and collaborators who have supported my journey. I look forward to engaging with the ISCTM community and contributing to discussions on clinical trial methodology in psychiatry!
February 18, 2025 at 10:09 PM
A huge thank you to my mentors, colleagues, and collaborators who have supported my journey. I look forward to engaging with the ISCTM community and contributing to discussions on clinical trial methodology in psychiatry!
It's officially fall and Kernel is on the move! First stop: Amsterdam for the #ISCTM Autumn Conference.
You can find our CEO, Ryan Field, at the poster session & reception on Oct. 10 from 6:00 - 7:30 p.m. presenting our latest work on #depression severity monitoring in #clinicaltrials.
You can find our CEO, Ryan Field, at the poster session & reception on Oct. 10 from 6:00 - 7:30 p.m. presenting our latest work on #depression severity monitoring in #clinicaltrials.
October 3, 2025 at 5:34 PM
It's officially fall and Kernel is on the move! First stop: Amsterdam for the #ISCTM Autumn Conference.
You can find our CEO, Ryan Field, at the poster session & reception on Oct. 10 from 6:00 - 7:30 p.m. presenting our latest work on #depression severity monitoring in #clinicaltrials.
You can find our CEO, Ryan Field, at the poster session & reception on Oct. 10 from 6:00 - 7:30 p.m. presenting our latest work on #depression severity monitoring in #clinicaltrials.
We had a great time presenting at ISCTM!
Our team was at #ISCTM to present a meta-analysis exploring the impact of clinical trial design factors on placebo effect in #MDD trials. Key finding links number & frequency of clinician-administered assessments to increased placebo response. Read more: bit.ly/3Qsz8bx
February 21, 2025 at 1:49 PM
We had a great time presenting at ISCTM!
What a fantastic start to ISCTM 2025 in Washington DC today! Fantastic talks on novel regulatory science precedents in Alzheimer's, ALS and Schizophrenia, and discussions of their implications for neuroscience!
February 20, 2025 at 4:33 AM
What a fantastic start to ISCTM 2025 in Washington DC today! Fantastic talks on novel regulatory science precedents in Alzheimer's, ALS and Schizophrenia, and discussions of their implications for neuroscience!
Our team was at #ISCTM to present a meta-analysis exploring the impact of clinical trial design factors on placebo effect in #MDD trials. Key finding links number & frequency of clinician-administered assessments to increased placebo response. Read more: bit.ly/3Qsz8bx
February 21, 2025 at 12:04 PM
Our team was at #ISCTM to present a meta-analysis exploring the impact of clinical trial design factors on placebo effect in #MDD trials. Key finding links number & frequency of clinician-administered assessments to increased placebo response. Read more: bit.ly/3Qsz8bx